$HSTM

HealthStream (NASDAQ:HSTM) Declares Stock Buyback Program

HealthStream (NASDAQ:HSTM) announced that its Board of Directors has approved a stock buyback program of $10.0 million, allowing the repurchase of up to 1.7% of its shares. This decision often signals the board's belief that the company's shares are undervalued. The company also reported strong quarterly earnings, beating analyst expectations, and increased its quarterly dividend.

Original reporting
MarketBeat · MarketBeat
Published Mar 14, 2026, 2:16 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 14, 2026, 3:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HealthStream (NASDAQ:HSTM) Declares Stock Buyback Program — source image
Decision brief

The 30-second read

$HSTMBullishMed
01

Why it matters

The buyback and earnings beat likely reflect strong operational performance, which could lead to increased investor confidence.

02

Market read

The news is highly relevant for investors holding or considering HSTM, with potential short-term price appreciation.

03

What to watch

Potential macroeconomic headwinds or sector-specific challenges could offset the positive effects of the buyback and earnings beat.

Timing: Immediate, as the buyback program is announced now and may influence trading today and in the near future.

Background

HealthStream is a provider of workforce solutions for the healthcare industry, with recent positive earnings and strategic initiatives.

Company-level read

Ticker impact

$HSTMBullishHigh confidence
Context

The news directly pertains to HealthStream (NASDAQ:HSTM), indicating a positive corporate action and strong earnings report.

Expected impact

Moderate upward pressure on HSTM stock in the short to medium term.

Evidence & confidence

The buyback reduces share count, potentially increasing earnings per share, while earnings beat expectations reinforce positive sentiment. The combined effect is likely to support a price increase.

Market effects

The health technology and life sciences sectors may see positive sentiment, especially if other companies announce buybacks or earnings beats.

Limited regional impact; primarily affects US-based healthcare and tech sectors.

Minimal; the news is company-specific with limited global market implications.

Counterpoint

Some investors may view the buyback as a sign that the company lacks better growth opportunities, potentially limiting future upside.

Key entities

  • HealthStream, Inc.

    A provider of workforce solutions for the healthcare industry.

Related articles

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.